RecruitingNCT06427304
Cardiac Amyloidosis pRevaleNce of in OLDer Subjects Affected by Heart Failure
Sponsor
Gérond'if
Enrollment
637 participants
Start Date
Jul 1, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
Tne aim purpose of this observational, multicentre and propective study is to determine the prevalence of cardiac amyloidosis in geriatric patients aged 80 years and older hospitalized within the last 12 months for heart failure with left ventricular hypertrophy (septum ≥ 12 mm) on echocardiography
Eligibility
Min Age: 80 Years
Inclusion Criteria5
- Aged ≥ 80 years
- Hospitalised for decompensation of heart failure in the last 12 months
- Subjects with hypertrophy of the septum or left ventricle at cardiac echography (defined as ≥ 12 mm)
- Subjects able to undergo a bone scintigraphy scan
- Subjects willing to participate
Exclusion Criteria4
- Subjects refusing to participate
- Subjects admitted to palliative care unit.
- Subjects under guardianship
- Subjects with a definite diagnosis of cardiac amyloidosis
Locations(36)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06427304
Related Trials
[18F]FT8 PET Imaging in Immunoglobulin Light Chain Amyloidosis
NCT072324592 locations
US Benchmarking Clinical Study
NCT072157153 locations
Cardiac Amyloid Deposits and Heart Dysfunction in Alzheimer's Disease
NCT071543941 location
Pan-Amyloid PET/CT in Various Amyloid-Related Disease
NCT071305652 locations
CAPACITY (Cardiac Amyloidosis and Physical ACtivITY) Study
NCT060966751 location